Background: Several cases of Kawasaki disease, (KD), up to 15%, were unresponsive to the initial treatment with intravenous immunoglobulin (IVIG). We retrospectively analyzed all children admitted for KD to determine the occurrence and variables associated with the initial IVIG treatment failure. Methods: All patients who fulfilled the criteria for KD and were treated with a single dose (2g/kg) of IVIG between January 1995 and December 2000 were enrolled. An analysis of patients who had initially failed to respond to IVIG and patients who had coronary artery aneurysm (CAA) was conducted. Results : A total of 113 patients were enrolled during the study period. There were 65 boys (57.5%). Thirteen patients (11.5%) were found to be unresponsive to initial IVIG treatment. Patients who were anemic (Hb Ͻ 10 gm/dl), had high leukocyte (wbc) counts (Ͼ12,000/mm3), and high neutrophil count (Ͼ75%) were at risk for failure to response to a single dose of IVIG. We found no correlation between age, gender, days of starting IVIG treatment and ESR with failure of initial IVIG treatment. There were 23 patients (20.3%) who developed CAA. Male gender, lower hemoglobin (Ͻ10 g/dl), higher neutrophil count (Ͼ75%), higher ESR (Ͼ100mm/hr), prolonged fever and failure to respond to a single dose of IVIG were associated with a higher risk of developing CAA. Conclusions: The failure of a single dose of IVIG treatment could be seen in up to 11.5% of our Kawasaki patients. We found that low hemoglobin (Ͻ10g/dl), high wbc counts (Ͼ12,000/mm3) and high neutrophil counts (Ͼ75%) were associated with retreatment of a second dose of IVIG.
KINETICS OF SERUM IMMUNOGLOBULINS IN KAWASAKI DISEASE: ARE THEY PREDICTORS FOR CORONARY OUTCOME ?
Shirley ML Tse, Rae SM Yeung Division of Rheumatology, Hospital for Sick Children, Toronto, ON, Canada Background: Immunoglobulins(Ig), such as IgA, have been found in affected coronary arteries in Kawasaki Disease(KD). Changes in Ig may reflect the development of coronary artery lesions(CAL). Objectives: To characterize changes in serum Ig during the course of KD and to determine whether Ig were predictive of coronary outcome. Methods: 243 KD pts(1995 243 KD pts( -2001 were included in this retrospective study. Data retrieved consisted of demographics and clinical course including lab tests from pre-treatment to 1yr post KD diagnosis(i.e. pre/post-IVIG, subacute, convalescent, 1yr). The quantitative variables were tested for their significance using the Student t test. Results: The mean age of pts was 3.7Ϯ2.8yrs. 66.3% were males and 33.7% were females. All received IVIG(2g/kg) and ASA. 19.3% required adjunctive therapy(multiple IVIGϮcorticosteroids). CAL detected at KD diagnosis, 3mos and 1yr comprised of ectasias (49.0%,31.3%,14.0%), aneurysms(3.3%,2.9%,1.2%) and giant aneurysms(0%,0.4%,0%). 93 pts had paired pre/post-IVIG Ig. Immediately post IVIG, the mean change in Ig was an increase IgG(70.9Ϯ16.8%), IgM(2.3Ϯ21.2%) and a decrease IgA(-8.5Ϯ20.4%). 43 pts had paired pre/subacute Ig. In this case, the mean change in Ig was an increase IgG(34.8Ϯ47.7%), IgM(13.7Ϯ36.4%) and a decrease IgA (-15.4Ϯ65.1%) . No significant differences were noted in pts with giant aneurysms and Ig levels. Significant serologic markers associated with CAL were decreased subacute IgG&IgA(acute ectasias), increased post-IgG&decreased pre/postIgM(persistent ectasias), and increased pre/convalescent-IgA&convalescent-IgG(persistent aneurysms). Consistent with Harada's risk factors, a lower PLT(pϭ0.04) and higher ESR(pϭ0.008) were associated with CAL. Persistent CAL were associated with a lower albumin(pϭ0.02) and a larger fall in the WBC post-IVIG(pϭ0.03). 
PREDICTION OF RESISTANCE TO TWO INTRAVENOUS INFUSIONS OF HIGH-DOSE ⌫ -GLOBULIN IN PATIENTS WITH KAWASAKI DISEASE BEFORE TREATMENT
Tetsuya Sano, Toshisaburo Nagai, Ichiro Maki, Takehisa Yamamoto, Kohshi Matsuzaki, Kazunori Miki, Tohru Matsushita, Takashi Onodera, Shunji Kurotobi, Junichi Hara Osaka Cooperative Study Group for Kawasaki Disease (Osaka Kosei-nenkin Hospital, Toyonaka-, Ikeda-, Minoo-, Suita-, Itami-Municipal Hospitals and Faculty of Medicine, Osaka University), Osaka, Japan Approximately 5 to 15% of patients with acute Kawasaki disease (KD) is non-responsive to intravenous ␥ -globulin (IVGG), which is one of critical risk factors of severe coronary artery injury. To determine how to predict IVGG-resistance before treatment, the correlation between the response to IVGG and clinical parameters at disease onset were analyzed in 112 children with acute KD treated with IVGG (1g/kg for two day) consecutively in six hospitals. Patients were classified as IVGGresponsive which was defined as defevescence within 24 hours after finishing IVGG (nϭ90) or IVGG-resistant as conistent fever over 24 hours after IVGG (nϭ22). An incident of coronary artery abnormalities during the acute phase was significantly higher (pϽ0.0001) in the IVGG-resistant group (50%) than in the IVGG-responsive group (11%), and so was that in the recovery phase (12% vs. 0%, pϭ0.0012). By an univariate analysis the IVGG-resistant group showed significantly higher serum levels of C-reactive protein (CRP), total bilirubin, aspertate aminotransferase (AST), alanine aminotransferase, lactate dehydrogeas (pϽ0.0001 in each), &gamma-glutamyltranspeptidase (pϭ0.02639) and neutrophil count (pϭ0.0159), as well as showed sigficantly lower serum albumin level (pϭ0.0181) than those in the IVGG-responsive group. A logistic regression analysis showed that as the appropriate cutoff values predicting the resistance to IVGG, a CRP level Ͼ7mg/dL (pϭ0.0104), a total bilirubin level Ͼ0.9mg/dL (pϭ0.0014) and an AST level Ͼ200IU/L (pϭ0.0031) were significant. Patients fitted in at least two of three cutoff values were considered resistant to IVGG (sensitivity ϭ 77% and specificity ϭ 86%). Alternative or additional therapy at an early stage of the disease should be considered for patients with acute KD who are predicted to be resistant to IVGG.
THE SELECTION OF THE GROUP WITH SUFFICIENT AND INSUFFI-CIENT EFFECT TO GAMMA GLOBULIN THERAPY IN THE KAWASAKI DISEASE
Michio Numata, Jun-ichi Hirao, Osamu Arisaka Department of Pediatrics, Dokkyo University, School of Medicine, Tochigi, Japan (Objective) The effectiveness of high dose intravenous gamma globulin (IVGG) therapy in the Kawasaki disease (KD) has already been established. This time, we originally produced the treatment protocol. Using this protocol, the groups with sufficient and insufficient effect to IVGG therapy were determined. In addition, frequency and characteristics of both group were analyzed. (Patients and methods) Forty five patients of starting the IVGG therapy within the seventh illness day were made to be an object. The IVGG therapy was done by following methods. The effect was judged after treatment start 48 hours. The IVGG therapy (1g/kg) was made to be an end, if there were antipyresis and improvement tendency of CRP. The effect insufficient cases added 1g/kg IVGG. As examination items, frequency of coronary artery lesions (CAL) and laboratory findings (CRP, WBC, PMN, Ht, Pl, Alb, ChE, IgG) were chosen. (Results) (1) The one time administrated group (A group) was 31 cases (69%), and the additional dosage group (B group) was 14 cases (31%). (2) The patients with CAL were 1/31 in the A group and 5/14 in the B group. (3) There was no significance at CRP, WBC, Ht, Pl, Alb in both groups. In the B group, PMN counts were significantly high, and ChE, IgG were significantly low. (Conclusions) (1) In about 70% of the cases, the sufficient effect was obtained in the single dose of 1g/kg IVGG therapy. (2) In the group with the sufficient effect, CAL could not be seldom recognized. (3) As a method of the selection of both groups, it seemed to be the most appropriate to judge the the therapy effect by the administration of 1g/kg IVGG. (4) It is possible that this therapy reduces the quantity of using IVGG, and there is an economical advantage.
